CAS: 908112-43-6
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide
CAS:908112-43-6
Formula:
C23H27F3N4O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
464.4807
Ref: IN-DA00GX4V
| 5mg | 56.00 € | ||
| 10mg | 89.00 € | ||
| 25mg | 145.00 € | ||
| 100mg | 306.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
SNX2112
CAS:908112-43-6
SNX2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM.
Formula:
C23H27F3N4O3
Purity:
98.9% - 99.46%
Color and Shape:
Solid
Molecular weight:
464.48
Ref: TM-T6305
| 1mg | 47.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 129.00 € | ||
| 25mg | 213.00 € | ||
| 50mg | 322.00 € | ||
| 100mg | 461.00 € | ||
| 200mg | 638.00 € | ||
| 1mL*10mM (DMSO) | 105.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
SNX-2112
Controlled ProductCAS:908112-43-6
Formula:
C23H27F3N4O3
Color and Shape:
Neat
Molecular weight:
464.481
Ref: TR-S590250
| 250mg | 5,796.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
SNX 2112
CAS:908112-43-6
Inhibitor of heat shock protein HSP90
Formula:
C23H27F3N4O3
Purity:
Min. 95%
Molecular weight:
464.48 g/mol
Ref: 3D-FS103989
| 5mg | 187.00 € | ||
| 10mg | 292.00 € | ||
| 25mg | 475.00 € | ||
| 50mg | 745.00 € | ||
| 100mg | 1,033.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
